Research ArticleExperimental Studies

p16 Methylation in Serum as a Potential Marker for the Malignancy of Colorectal Carcinoma

GORO NAKAYAMA, KENJI HIBI, YASUHIRO KODERA, MASAHIKO KOIKE, MICHITAKA FUJIWARA and AKIMASA NAKAO
Anticancer Research September 2007, 27 (5A) 3367-3370;

Article Information

vol. 27 no. 5A 3367-3370
PubMed 
17970082
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 1, 2007
  • Revision received July 26, 2007
  • Accepted August 1, 2007
  • Published online September 1, 2007.
Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. GORO NAKAYAMA1,
  2. KENJI HIBI1,2,
  3. YASUHIRO KODERA1,
  4. MASAHIKO KOIKE1,
  5. MICHITAKA FUJIWARA1 and
  6. AKIMASA NAKAO1
  1. 1Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550
  2. 2Department of Surgery, Showa University, Fujigaoka Hospital, Yokohama 227-8501, Japan
  1. Correspondence to: Kenji Hibi, Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya 466-8560, Japan. Tel: +81 527442245, Fax: +81 527442255, e-mail: kenjih-ngy{at}umin.ac.jp

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
p16 Methylation in Serum as a Potential Marker for the Malignancy of Colorectal Carcinoma
GORO NAKAYAMA, KENJI HIBI, YASUHIRO KODERA, MASAHIKO KOIKE, MICHITAKA FUJIWARA, AKIMASA NAKAO
Anticancer Research Sep 2007, 27 (5A) 3367-3370;
Twitter logo Facebook logo Mendeley logo

Jump to section